Springfield Cannabis Workers Ratify Missouri's Second Union Contract
Four-year organizing effort ends with ratification at Springfield dispensary, marking rare labor win in state's cannabis sector.

Two male employees organizing products in a cozy grocery store.
Four-Year Timeline Reflects Industry-Wide Organizing Friction
The Springfield ratification took four years from initial organizing to contract signature, a timeline that mirrors the national pattern of protracted cannabis labor campaigns. Missouri legalized medical cannabis in 2018 and adult-use sales in 2023, but union density in the state's cannabis sector remains below 5%. The Springfield facility is only the second licensed operation in Missouri to finalize a collective bargaining agreement.
The delay isn't unusual. Cannabis employers frequently challenge union elections through administrative appeals, and the industry's federal illegality creates jurisdictional gray zones that slow National Labor Relations Board proceedings. Springfield workers voted to unionize in 2022. Contract negotiations stalled over wage floors and arbitration language until this month.
That four-year gap matters operationally. Turnover in non-union cannabis retail averages 60-75% annually, meaning many workers who voted in 2022 likely left before the contract took effect. The union had to maintain majority support through two election cycles and a change in state law.
Contract Terms Target Scheduling and Wage Compression
The ratified agreement includes minimum hourly rates for budtenders starting at $16.50 and guarantees two-week advance scheduling, addressing the two most common grievances in cannabis retail. Missouri's minimum wage is $13.75 as of 2026, so the union secured a 20% premium over the state floor. Cultivation staff received a separate wage scale starting at $18.00 per hour.
Scheduling predictability is the sleeper issue here. Cannabis retail operates seven days a week with peak traffic on weekends and paydays, creating unpredictable shift patterns that destabilize workers' second jobs or childcare. The two-week notice requirement forces managers to plan labor allocation in advance rather than texting workers the night before a shift.
Wage compression was a sticking point. The contract includes annual step increases capped at 4%, which the employer said was necessary given Missouri's 280E tax burden. The union accepted the cap in exchange for a grievance process that allows workers to challenge disciplinary actions without risking at-will termination.
Missouri's Union Landscape Remains Sparse Compared to Illinois
Only two Missouri cannabis facilities now operate under union contracts, compared to 47 in neighboring Illinois, where labor organizing began earlier and faced less employer resistance. Illinois legalized adult-use sales in January 2020, three years before Missouri, giving unions a head start. Illinois also tied social-equity licensing to labor-peace agreements, creating a structural incentive for operators to recognize unions voluntarily.
Missouri has no equivalent labor-peace statute. Operators can challenge union elections and drag out contract negotiations without risking their license renewal. That legal asymmetry explains why Missouri's union density lags Illinois by a factor of 20 despite comparable market size.
The Springfield contract doesn't change that calculus statewide. But it does create a wage-and-scheduling benchmark that non-union competitors will now have to match or explain. If turnover drops at the Springfield facility, that's a data point other operators can't ignore.
What to Watch: Contract Enforcement and Turnover Metrics
The real test of this contract isn't the signature. It's whether the grievance process functions and whether turnover falls below the industry average over the next 12 months. Cannabis union contracts often include strong language on paper but weak enforcement mechanisms in practice. Arbitration clauses are only as good as the union's willingness to fund arbitration, which costs $10,000-$15,000 per case.
Turnover is the leading indicator. If the Springfield facility retains 70% of its workforce year-over-year, that's a signal the scheduling and wage provisions are working. If turnover stays at 60%, the contract is decorative. We'll be tracking Missouri Division of Cannabis Regulation employment data to see whether this facility's headcount stabilizes relative to non-union competitors.
What happens next depends on perception. Missouri has six licensed dispensaries in Greene County. If workers at competing facilities see the Springfield contract as a model, the organizing wave could accelerate. If they see it as a four-year slog with modest gains, momentum stalls. The next six months will clarify which narrative takes hold.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Baby Boomers Drive $500M Cannabis Market Across Michigan, Ohio
Consumers aged 60+ now account for half a billion dollars in annual sales across the two Midwest adult-use states.

Illinois THC Beverage Ban Threatens Lifeline for Local Breweries
State regulators may shut down hemp-derived THC drinks by year's end, jeopardizing revenue stream that rescued struggling craft brewers.

Aurora Cannabis Refutes Curaleaf Claims in Hostile Takeover Defense
Aurora Cannabis (ACB) publicly disputed statements made by Curaleaf Holdings in support of its unsolicited acquisition proposal.
More from the newsroom

California Lawmakers Approve Bill Restricting Child-Attractive Cannabis Packaging
The legislation bans cannabis product packaging designed to appeal to minors, moving to the governor's desk.

Massachusetts Voters Back Psychedelics Ballot Measure in August Poll
A new survey shows majority support for the state's November psychedelics legalization question, with cannabis-related measures also polling favorably.

Daily Marijuana Use Surpasses Alcohol and Cigarettes, Federal Data Shows
Cannabis overtakes traditional substances in daily-use prevalence for the first time in U.S. tracking history.